Is XGN or EUDA more profitable?

EUDA Health has a net margin of 0.00% compared to Exagen's net margin of -29.49%. EUDA Health's return on equity of 0.00% beat Exagen's return on equity. Company Net Margins Return on Equity Return on Assets Exagen -29.49% -94.37% -28.96% EUDA Health N/A N/A N/A

Does the media favor EUDA or PIII?

In the previous week, P3 Health Partners had 1 more articles in the media than EUDA Health. MarketBeat recorded 4 mentions for P3 Health Partners and 3 mentions for EUDA Health. P3 Health Partners' average media sentiment score of 1.26 beat EUDA Health's score of 0.96 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive P3 Health Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer EUDA or BNR?

EUDA Health presently has a consensus target price of $55.00, suggesting a potential upside of 278.66%. Given EUDA Health's stronger consensus rating and higher probable upside, equities analysts clearly believe EUDA Health is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, EUDA or PARK?

Park Dental Partners has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M 6.37 -$2.77M -$2.40 N/A Park Dental Partners $248.15M 0.38 -$360K N/A N/A

Is EUDA or PARK more profitable?

Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Park Dental Partners N/A N/A N/A

Does the media favor EUDA or PARK?

In the previous week, EUDA Health and EUDA Health both had 3 articles in the media. Park Dental Partners' average media sentiment score of 1.12 beat EUDA Health's score of 0.96 indicating that Park Dental Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Park Dental Partners 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to EUDA or SERA?

In the previous week, EUDA Health and EUDA Health both had 3 articles in the media. EUDA Health's average media sentiment score of 0.96 beat Sera Prognostics' score of 0.63 indicating that EUDA Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sera Prognostics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

EUDA Health (EUDA) Competitors

$14.52 -0.69 (-4.50%)

Closing price 03:58 PM Eastern

Extended Trading

$14.52 -0.01 (-0.07%)

As of 04:10 PM Eastern

Compare

EUDA vs. XGN, PIII, BNR, PARK, and SERA

Should you buy EUDA Health stock or one of its competitors? MarketBeat compares EUDA Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with EUDA Health include Exagen (XGN), P3 Health Partners (PIII), Burning Rock Biotech (BNR), Park Dental Partners (PARK), and Sera Prognostics (SERA). These companies are all part of the "healthcare" industry.

How does EUDA Health compare to Exagen?

Exagen (NASDAQ:XGN) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

In the previous week, EUDA Health had 1 more articles in the media than Exagen. MarketBeat recorded 3 mentions for EUDA Health and 2 mentions for Exagen. Exagen's average media sentiment score of 1.93 beat EUDA Health's score of 0.96 indicating that Exagen is being referred to more favorably in the media.

Company	Overall Sentiment
Exagen	Very Positive
EUDA Health	Positive

EUDA Health has lower revenue, but higher earnings than Exagen. EUDA Health is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$66.57M	1.72	-$19.95M	-$0.89	N/A
EUDA Health	$6.82M	6.37	-$2.77M	-$2.40	N/A

Exagen has a beta of 2.01, meaning that its share price is 101% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to Exagen's net margin of -29.49%. EUDA Health's return on equity of 0.00% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-29.49%	-94.37%	-28.96%
EUDA Health	N/A	N/A	N/A

Exagen presently has a consensus target price of $9.11, indicating a potential upside of 91.81%. EUDA Health has a consensus target price of $55.00, indicating a potential upside of 278.66%. Given EUDA Health's higher possible upside, analysts plainly believe EUDA Health is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.90
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

75.3% of Exagen shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 10.4% of Exagen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Exagen beats EUDA Health on 10 of the 17 factors compared between the two stocks.

How does EUDA Health compare to P3 Health Partners?

EUDA Health (NASDAQ:EUDA) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

EUDA Health has higher earnings, but lower revenue than P3 Health Partners. EUDA Health is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.37	-$2.77M	-$2.40	N/A
P3 Health Partners	$1.46B	0.06	-$147.95M	-$38.60	N/A

EUDA Health has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%. EUDA Health's return on equity of 0.00% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
P3 Health Partners	-8.57%	-302.33%	-19.99%

EUDA Health currently has a consensus target price of $55.00, indicating a potential upside of 278.66%. P3 Health Partners has a consensus target price of $14.00, indicating a potential upside of 17.25%. Given EUDA Health's higher probable upside, equities analysts plainly believe EUDA Health is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

EUDA Health has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market. Comparatively, P3 Health Partners has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market.

In the previous week, P3 Health Partners had 1 more articles in the media than EUDA Health. MarketBeat recorded 4 mentions for P3 Health Partners and 3 mentions for EUDA Health. P3 Health Partners' average media sentiment score of 1.26 beat EUDA Health's score of 0.96 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
P3 Health Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

EUDA Health and P3 Health Partners tied by winning 7 of the 14 factors compared between the two stocks.

How does EUDA Health compare to Burning Rock Biotech?

EUDA Health (NASDAQ:EUDA) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

EUDA Health has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Burning Rock Biotech has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -11.57%. EUDA Health's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Burning Rock Biotech	-11.57%	-10.98%	-7.33%

EUDA Health presently has a consensus target price of $55.00, suggesting a potential upside of 278.66%. Given EUDA Health's stronger consensus rating and higher probable upside, equities analysts clearly believe EUDA Health is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

EUDA Health has higher earnings, but lower revenue than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than EUDA Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.37	-$2.77M	-$2.40	N/A
Burning Rock Biotech	$77.16M	1.10	-$7.92M	-$0.82	N/A

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, EUDA Health had 2 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for EUDA Health and 1 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 1.89 beat EUDA Health's score of 0.96 indicating that Burning Rock Biotech is being referred to more favorably in the news media.

Company	Overall Sentiment
EUDA Health	Positive
Burning Rock Biotech	Very Positive

Summary

EUDA Health beats Burning Rock Biotech on 10 of the 16 factors compared between the two stocks.

How does EUDA Health compare to Park Dental Partners?

EUDA Health (NASDAQ:EUDA) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

EUDA Health presently has a consensus price target of $55.00, indicating a potential upside of 278.66%. Park Dental Partners has a consensus price target of $21.75, indicating a potential upside of 3.33%. Given EUDA Health's higher possible upside, equities analysts clearly believe EUDA Health is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	2.75

Park Dental Partners has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.37	-$2.77M	-$2.40	N/A
Park Dental Partners	$248.15M	0.38	-$360K	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Park Dental Partners	N/A	N/A	N/A

4.4% of EUDA Health shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, EUDA Health and EUDA Health both had 3 articles in the media. Park Dental Partners' average media sentiment score of 1.12 beat EUDA Health's score of 0.96 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Park Dental Partners	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Park Dental Partners beats EUDA Health on 6 of the 10 factors compared between the two stocks.

How does EUDA Health compare to Sera Prognostics?

EUDA Health (NASDAQ:EUDA) and Sera Prognostics (NASDAQ:SERA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

EUDA Health has higher revenue and earnings than Sera Prognostics. EUDA Health is trading at a lower price-to-earnings ratio than Sera Prognostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.37	-$2.77M	-$2.40	N/A
Sera Prognostics	$80K	886.00	-$31.93M	-$0.65	N/A

EUDA Health has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Sera Prognostics has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to Sera Prognostics' net margin of -56,385.97%. EUDA Health's return on equity of 0.00% beat Sera Prognostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Sera Prognostics	-56,385.97%	-41.02%	-30.95%

EUDA Health currently has a consensus target price of $55.00, suggesting a potential upside of 278.66%. Sera Prognostics has a consensus target price of $5.50, suggesting a potential upside of 203.87%. Given EUDA Health's higher probable upside, equities analysts clearly believe EUDA Health is more favorable than Sera Prognostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sera Prognostics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, EUDA Health and EUDA Health both had 3 articles in the media. EUDA Health's average media sentiment score of 0.96 beat Sera Prognostics' score of 0.63 indicating that EUDA Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sera Prognostics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 54.6% of Sera Prognostics shares are held by institutional investors. 11.3% of Sera Prognostics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Sera Prognostics beats EUDA Health on 8 of the 15 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EUDA vs. The Competition

Export

Metric	EUDA Health	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$43.43M	$1.73B	$6.85B	$12.43B
Dividend Yield	N/A	N/A	2.67%	6.11%
P/E Ratio	-6.05	79.65	25.82	24.36
Price / Sales	6.37	7.25	549.91	101.32
Price / Cash	N/A	24.73	29.09	36.93
Price / Book	-6.43	5.63	10.97	6.50
Net Income	-$2.77M	-$54.76M	$3.58B	$336.61M
7 Day Performance	1.72%	5.61%	3.00%	0.89%
1 Month Performance	-19.57%	-1.66%	0.67%	-0.36%
1 Year Performance	-78.83%	2.54%	36.72%	31.12%

EUDA Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EUDA EUDA Health	2.4121 of 5 stars	$14.53 -4.5%	$55.00 +278.7%	-77.8%	$43.43M	$6.82M	N/A	2	Short Interest Decrease Gap Down
XGN Exagen	4.3314 of 5 stars	$4.52 +3.7%	$9.11 +101.6%	-34.6%	$105.22M	$66.57M	N/A	220	Positive News
PIII P3 Health Partners	2.8153 of 5 stars	$11.14 -7.1%	$14.00 +25.7%	+77.6%	$86.87M	$1.46B	N/A	500	Positive News Short Interest Decrease
BNR Burning Rock Biotech	1.7813 of 5 stars	$8.52 +12.7%	N/A	+168.9%	$79.52M	$77.16M	N/A	1,390	Gap Up High Trading Volume
PARK Park Dental Partners	2.6736 of 5 stars	$17.30 -1.4%	$21.75 +25.7%	N/A	$79.24M	$244.49M	N/A	1,208	Short Interest Decrease High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EUDA) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EUDA Health (EUDA) Competitors

EUDA vs. XGN, PIII, BNR, PARK, and SERA

How does EUDA Health compare to Exagen?

Summary

How does EUDA Health compare to P3 Health Partners?

Summary

How does EUDA Health compare to Burning Rock Biotech?

Summary

How does EUDA Health compare to Park Dental Partners?

Summary

How does EUDA Health compare to Sera Prognostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EUDA Health (EUDA) Competitors

EUDA vs. XGN, PIII, BNR, PARK, and SERA

How does EUDA Health compare to Exagen?

Does the media refer more to XGN or EUDA?

Which has higher valuation & earnings, XGN or EUDA?

Which has more risk and volatility, XGN or EUDA?

Is XGN or EUDA more profitable?

Do analysts prefer XGN or EUDA?

Do insiders and institutionals hold more shares of XGN or EUDA?

Summary

How does EUDA Health compare to P3 Health Partners?

Which has preferable valuation and earnings, EUDA or PIII?

Is EUDA or PIII more profitable?

Do analysts prefer EUDA or PIII?

Do institutionals and insiders have more ownership in EUDA or PIII?

Which has more volatility & risk, EUDA or PIII?

Does the media favor EUDA or PIII?

Summary

How does EUDA Health compare to Burning Rock Biotech?

Which has more risk & volatility, EUDA or BNR?

Is EUDA or BNR more profitable?

Do analysts prefer EUDA or BNR?

Which has preferable earnings and valuation, EUDA or BNR?

Do insiders & institutionals hold more shares of EUDA or BNR?

Does the media prefer EUDA or BNR?

Summary

How does EUDA Health compare to Park Dental Partners?

Do analysts prefer EUDA or PARK?

Which has better valuation & earnings, EUDA or PARK?

Is EUDA or PARK more profitable?

Do insiders and institutionals believe in EUDA or PARK?

Does the media favor EUDA or PARK?

Summary

How does EUDA Health compare to Sera Prognostics?

Which has higher valuation and earnings, EUDA or SERA?

Which has more risk and volatility, EUDA or SERA?

Is EUDA or SERA more profitable?

Do analysts prefer EUDA or SERA?

Does the media refer more to EUDA or SERA?

Do insiders and institutionals hold more shares of EUDA or SERA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools